2012
DOI: 10.3111/13696998.2012.691144 View full text |Buy / Rent full text
|
|

Abstract: c i a l D i s t r i b u t i o n U n a u t h o r i z e d u s e p r o h i b i t e d . A u t h o r i s e d u s e r s c a n d o w n l o a d , d i s p l a y , v i e w a n d p r i n t a s i n g l e c o p y f o r p e r s o n a l u s eJournal of Medical Economics Vol. 15, No. 5, 2012, 878-886 Dabigatran etexilate is a new oral direct thrombin inhibitor for prophylaxis of venous thromboembolism (VTE) in patients who have elective surgery for total hip replacement (THR) or total knee replacement (TKR). Among the adv… Show more

Help me understand this report

Search citation statements

Order By: Relevance
Select...
0
4
0

Publication Types

Select...

Relationship

0
0

Authors

Journals